.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Novartis
McKinsey
Medtronic
Farmers Insurance
Colorcon
UBS
Baxter
Federal Trade Commission
Deloitte

Generated: June 29, 2017

DrugPatentWatch Database Preview

VANSIL Drug Profile

« Back to Dashboard

What is the patent landscape for Vansil, and what generic Vansil alternatives are available?

Vansil is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in VANSIL is oxamniquine. Additional details are available on the oxamniquine profile page.

Summary for Tradename: VANSIL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list11
Patent Applications: see list606
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VANSIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
VANSIL
oxamniquine
CAPSULE;ORAL018069-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VANSIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
VANSIL
oxamniquine
CAPSULE;ORAL018069-001Approved Prior to Jan 1, 19823,821,228► Subscribe
Pfizer
VANSIL
oxamniquine
CAPSULE;ORAL018069-001Approved Prior to Jan 1, 19823,925,391► Subscribe
Pfizer
VANSIL
oxamniquine
CAPSULE;ORAL018069-001Approved Prior to Jan 1, 19823,903,283► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cipla
US Department of Justice
Chubb
US Army
Johnson and Johnson
Express Scripts
Fuji
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot